TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients
PICKERING, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) -- TJP Labs Inc. ("TJP Labs") is North America's leading full-service contract manufacturer of premier next-generation products, focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceutical products. Today, TJP Labs announced that after completing a thorough regulatory assessment and meeting all GMP requirements, it received a notice of compliance for Active Pharmaceutical Ingredients (API) following an audit by the Health Canada Drug GMP Inspection Program.
The announcement aligns with TJP Labs' strategy to offer drug manufacturing services, and the new achievement enables TJP Labs to spearhead further licensable activities.
Speaking on the achievement, David Richmond-Peck, CEO of TJP Labs, remarked:
"I cannot overstate the significance of this most recent compliant rating by Health Canada, and I congratulate our quality and manufacturing teams on their continued success.
GMP certification for Active Pharmaceutical Ingredients accelerates TJP's bold innovation strategy in the modern oral and beyond nicotine categories. Furthermore, it reinforces that our facilities operate to a set of internationally recognized pharmaceutical standards to ensure product quality and safety.
The modern oral category is seeing exponential growth and this critical API milestone positions TJP as a formidable and aggressive partner. There is a growing demand for innovation, and our certifications give us the unique ability to provide more value-added products and services. But, most importantly, it allows us to offer a broad range of best-in-class products across multiple categories. It also enhances TJP's long-term value for our investors."
About TJP Labs Inc.
TJP Labs is a leading North American full-service manufacturer of premium quality next-generation products, specializing in modern oral nicotine, energy, and nutraceutical pouches. Our products are manufactured and packaged in our DEL, Site-Licensed, cGMP/HACCP compliant, ISO 9001:2015 certified state-of-the-art facilities.
David Richmond-Peck - firstname.lastname@example.org
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Correction: AB Linas Agro Group investors calendar for the 20232.12.2022 08:00:43 CET | Press release
A list of key information disclosure dates in 2023: February 28, 2023Interim half-year unaudited report for FY 2022/2023.March 1, 2023Investor Conference Webinar to introduce unaudited financial and activity results for the half-year of FY 2022/2023.May 31, 2023Interim unaudited report for 9 months of FY 2022/2023.June 1, 2023Investor Conference Webinar to introduce unaudited financial and activity results for 9 months of FY 2022/2023.August 31, 2023Interim unaudited report for 12 months of FY 2022/2023.September 4, 2023Investor Conference Webinar to introduce unaudited financial and activity results for 12 months of FY 2022/2023.Week 40 (Oct 2-6, 2023)Notice on Annual General Meeting of shareholders.Week 43 (Oct 23-27, 2023)Resolutions of the Annual General Meeting of shareholders and Annual audited results for FY 2022/2023.November 30, 2023Interim unaudited report for 3 months of 2023/2024 financial year.December 1, 2023Investor Conference Webinar to introduce unaudited financial and
PRESS RELEASE: NACON UNVEILS THE MG-X PRO MADE FOR iPHONE®2.12.2022 08:00:00 CET | Press release
NACON UNVEILS THE MG-X PRO MADE FOR iPHONE® Lesquin, 2 December 2022 – The premium gaming accessories designer NACON is pleased to announce the launch of its new MG-X Pro Made For iPhone® controller. The officially licensed Xbox MG-X Pro Made For iPhone® cloud-gaming controller is the ideal controller for subscribers to Xbox Game Pass Ultimate™. Like the MG-X Pro for Android, which has won critical acclaim since its release in January 2022, the MG-X Pro Made For iPhone® provides all the classic controls of an Xbox controller for cloud gaming on mobile with Game Pass Ultimate™ and with any compatible game in the Apple Store. The MG-X Pro Made for iPhone® is compatible with a wide range of iPhone® models, from the 6S to the latest, thanks to its adjustable holder and Bluetooth® connectivity. The MG-X Pro Made For iPhone® connects to your iPhone® in mere seconds and lets you play all games available in Xbox Game Pass Ultimate™. The ergonomic handles, asymmetric sticks, bumpers, triggers,
KBC Group: KBC Bank Ireland welcomes decision of Minister for Finance to approve the sale of substantially all of its performing loan assets and liabilities to Bank of Ireland Group2.12.2022 08:00:00 CET | Press release
Press Release Outside trading hours – Regulated information* Brussels, 2 December 2022 (8 a.m. CET, before Brussels stock exchange hours) KBC Bank Ireland welcomes decision of Minister for Finance to approve the sale of substantially all of its performing loan assets and liabilities to Bank of Ireland Group. On the 16th of April 2021, KBC Group announced that KBC Bank Ireland had entered into a Memorandum of Understanding (MoU) with Bank of Ireland Group. On the 22nd of October 2021 KBC Bank Ireland entered into a legally binding agreement with Bank of Ireland Group whereby it would acquire substantially all of KBC Bank Ireland’s performing loan assets and deposits. In addition, a small portfolio of non-performing mortgages (NPEs) will also be acquired as part of the transaction. On the 24th of May 2022 the transaction received approval from the Irish Competition and Consumer Protection Commission (CCPC), and today, 2 December 2022, KBC can confirm that the deal received final approval
Mining sector puts energy into ESG, but lacks focus on gender and diversity2.12.2022 08:00:00 CET | Press release
Demand for greater transparency fuels shift in sustainable approach, finds new survey LONDON, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Energy efficiency has soared up the list of environmental priorities for the mining industry and now features in the top three for most companies, along with air and water pollution and waste management. It’s one of the key findings from a survey of global mining sector decision-makers published today by mining executive search and recruitment consultants, Stratum International, and independent ESG accreditors, Digbee. Tackling climate change and biodiversity loss come lower on the list of environmental, social and governance (ESG) factors for many mining businesses, according to the new report. And there’s a concerning lack of focus on gender and diversity for a sector which needs to change the perception that mining is a male-only environment. The issue is deemed the “least important” social priority for mining companies over the next two years. Will Coetzer
Press Release: Statement from Sanofi regarding: rule 2.12 of the takeover rules2.12.2022 07:55:00 CET | Press release
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE "TAKEOVER RULES"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. DECEMBER 2, 2022 Statement from Sanofi regarding: rule 2.12 of the takeover rules Paris, December 2, 2022. As required by Rule 2.12 of the Takeover Rules, Sanofi S.A. (“Sanofi”) confirms that any offer for Horizon Therapeutics plc, if made by Sanofi, will be solely in cash. There is no certainty that any offer will be made, nor as to the terms on which any such offer may be made, if forthcoming. About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible